nach oben

Erschienen in:

01.08.2021 | Review

Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel

verfasst von: Wubshet H. Tesfaye, Daniel Erku, Alemayehu Mekonnen, Yonas Getaye Tefera, Ronald Castelino, Kamal Sud, Jackson Thomas, Kehinde Obamiro

Erschienen in: Journal of Nephrology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Medication non-adherence is a well-recognised issue in chronic diseases but data in patients with chronic kidney disease (CKD) not receiving kidney replacement therapy (KRT) remains limited. This review summarised the prevalence of medication non-adherence and assessed determinants and outcomes associated with it in adults with CKD, not on KRT.

Method

We searched PubMed, Embase, PsychInfo, Web of Science, and Cochrane (CENTRAL) for studies published until January 2020. Pooled prevalence of medication non-adherence was reported. Determinants of adherence—identified from quantitative and qualitative studies—were mapped into the theoretical domains framework and interventions proposed using the behavioural change wheel.

Results

Twenty-seven studies (22 quantitative and 5 qualitative) were included. The pooled prevalence of medication non-adherence was 39% (95% CI 30–48%). Nine studies reported association between non-adherence and outcomes, including blood pressure, disease progression, adverse events, and mortality. Modifiable determinants of non-adherence were mapped into 11 of the 14 Theoretical Domains Framework—of which, six appeared most relevant. Non-adherence decisions were usually due to lack of knowledge on CKD, comorbidities, and medications; polypharmacy and occurrence of medication side effects; changes in established routines such as frequent medication changes; higher medication cost, poor accessibility to medications, services and facilities; inadequate patient-healthcare professional communication; and forgetfulness. Using the behavioural change wheel, we identified several areas where interventions can be directed to improve medication adherence.

Conclusion

Medication non-adherence is common in adults with CKD, not on KRT and may lead to poor outcomes. Evidence synthesis using mixed study designs was crucial in identifying determinants of non-adherence, drawing on a parsimonious approach from behaviour science.

PROSPERO registration

CRD42020149983.

Graphic abstract

Nur mit Berechtigung zugänglich

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY-M, Yang C-W (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260–272PubMedCrossRef

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M (2017) Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 13(7):393PubMedCrossRef

Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Bello A, James M, Turin TC, Tonelli M (2011) Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med 171(21):1920–1927PubMedCrossRef

Roy L, White-Guay B, Dorais M, Dragomir A, Lessard M, Perreault S (2013) Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney Int 84(3):570–577PubMedCrossRef

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV (2015) Cause-specific deaths in non-dialysis-dependent CKD. J Am Soc Nephrol 26(10):2512–2520PubMedCrossRefPubMedCentral

Sarnak MJ (2003) Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 41:11–17PubMedCrossRef

Horne R, Weinman J, Barber N, Elliott R, Morgan M, Cribb A, Kellar I (2005) Concordance, adherence and compliance in medicine taking. NCCSDO, London, pp 40–46

Richardson M, Khouja CL, Sutcliffe K, Thomas JJ (2019) Using the theoretical domains framework and the behavioural change wheel in an overarching synthesis of systematic reviews. BMJ Open 9(6):e024950PubMedCrossRefPubMedCentral

Michie S, Johnston M, Francis J, Hardeman W, Eccles MJ (2008) From theory to intervention: mapping theoretically derived behavioural determinants to behaviour change techniques. Appl Psychol 57(4):660–680CrossRef

10.

Abdou JK, Auyeung V, Patel JP, Arya R (2016) Adherence to long-term anticoagulation treatment, what is known and what the future might hold. Br J Haematol 174(1):30–42. https://doi.org/10.1111/bjh.14134CrossRefPubMed

11.

Crayton E, Fahey M, Ashworth M, Besser SJ, Weinman J, Wright AJ (2017) Psychological determinants of medication adherence in stroke survivors: a systematic review of observational studies. Ann Behav Med 51(6):833–845PubMedCrossRef

12.

Presseau J, Schwalm J, Grimshaw JM, Witteman HO, Natarajan MK, Linklater S, Sullivan K, Ivers NM (2017) Identifying determinants of medication adherence following myocardial infarction using the theoretical domains framework and the health action process approach. Psychol Health 32(10):1176–1194PubMedCrossRef

13.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM (2016) Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine 95(15):e3361PubMedCrossRefPubMedCentral

14.

Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ (2006) Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 166(17):1836–1841CrossRefPubMed

15.

Horwitz RI, Viscoli CM, Donaldson R, Murray C, Ransohoff D, Berkman L, Horwitz S, Sindelar J (1990) Treatment adherence and risk of death after a myocardial infarction. Lancet 336(8714):542–545PubMedCrossRef

16.

Xu T, Yu X, Ou S, Liu X, Yuan J, Tan X, Chen Y (2017) Adherence to antihypertensive medications and stroke risk: a dose-response meta-analysis. J Am Heart Assoc 6(7):e006371PubMedCrossRefPubMedCentral

17.

Murali KM, Mullan J, Chen JH, Roodenrys S, Lonergan M (2017) Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: a systematic review. BMC Nephrol 18(1):42PubMedCrossRefPubMedCentral

18.

Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi ST (2015) Nonadherence to medication therapy in haemodialysis patients: a systematic review. PLoS ONE 10(12):e0144119. https://doi.org/10.1371/journal.pone.0144119CrossRefPubMedPubMedCentral

19.

Karamanidou C, Clatworthy J, Weinman J, Horne R (2008) A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol 9:2. https://doi.org/10.1186/1471-2369-9-2CrossRefPubMedPubMedCentral

20.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097PubMedCrossRefPubMedCentral

21.

Covidence (2020) Cochrane Community. https://www.covidence.org/reviewers. Accessed 23 June 2020

22.

Joanna Briggs Institute reviewers’ manual: 2014 edition (2014). https://joannabriggs.org/ebp#tools. Accessed 08 July 2020

23.

Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8(1):45PubMedCrossRefPubMedCentral

24.

Langan D, Higgins JP, Jackson D, Bowden J, Veroniki AA, Kontopantelis E, Viechtbauer W, Simmonds M (2019) A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods 10(1):83–98PubMedCrossRef

25.

Harbord RM, Harris RJ, Sterne JA (2009) Updated tests for small-study effects in meta-analyses. Stata J 9(2):197–210CrossRef

26.

Cane J, O’Connor D, Michie S (2012) Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci 7(1):37PubMedCrossRefPubMedCentral

27.

Michie S, Van Stralen MM, West RJ (2011) The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 6(1):42PubMedCrossRefPubMedCentral

28.

Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, Eccles MP, Cane J, Wood CE (2013) The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 46(1):81–95PubMedCrossRef

29.

Balasubramaniam S, Lim SL, Goh LH, Subramaniam S, Tangiisuran B (2019) Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia. Diabetes Metab Syndr 13(4):2585–2591PubMedCrossRef

30.

Cedillo-Couvert EA, Ricardo AC, Chen J, Cohan J, Fischer MJ, Krousel-Wood M, Kusek JW, Lederer S, Lustigova E, Ojo A, Porter AC, Sharp LK, Sondheimer J, Diamantidis C, Wang X, Roy J, Lash JP (2018) Self-reported medication adherence and CKD progression. Kidney Int Rep 3(3):645–651. https://doi.org/10.1016/j.ekir.2018.01.007CrossRefPubMedPubMedCentral

31.

Curtin RB, Walters BAJ, Schatell D, Pennell P, Wise M, Klicko K (2008) Self-efficacy and self-management behaviors in patients with chronic kidney disease. Adv Chronic Kidney Dis 15(2):191–205PubMedCrossRef

32.

Garcia-Llana H, Remor E, Del Peso G, Celadilla O, Selgas R (2014) Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease. J Clin Psychol Med Settings 21(1):103–115PubMedCrossRef

33.

Gor D, Lee TA, Schumock GT, Walton SM, Gerber BS, Nutescu EA, Touchette DR (2020) Adherence and persistence with DPP-4 inhibitors versus pioglitazone in type 2 diabetes patients with chronic kidney disease: a retrospective claims database analysis. J Managed Care Spec Pharm 26(1):67–75. https://doi.org/10.18553/jmcp.2020.26.1.67CrossRef

34.

Han Y, Saran R, Erickson SR, Hirth RA, He K, Balkrishnan R (2019) Environmental and individual predictors of medication adherence among elderly patients with hypertension and chronic kidney disease: a geospatial approach. Res Social Adm Pharm. https://doi.org/10.1016/j.sapharm.2019.06.011CrossRefPubMedPubMedCentral

35.

Harris LE, Luft FC, Rudy DW, Tierney WMJ, Medicine (1995) Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal insufficiency. Soc Sci Med 41(12):1639–1645PubMedCrossRef

36.

Hong K, Muntner P, Kronish I, Shilane D, Chang TI (2016) Medication adherence and visit-to-visit variability of systolic blood pressure in African Americans with chronic kidney disease in the AASK trial. J Hum Hypertens 30(1):73–78PubMedCrossRef

37.

Hsu KL, Fink JC, Ginsberg JS, Yoffe M, Zhan M, Fink W, Woods CM, Diamantidis CJ (2015) Self-reported medication adherence and adverse patient safety events in CKD. Am J Kidney Dis 66(4):621–629PubMedCrossRefPubMedCentral

38.

Kefale B, Tadesse Y, Alebachew M, Engidawork E (2018) Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study. PLoS ONE 13(7):e0200415. https://doi.org/10.1371/journal.pone.0200415CrossRefPubMedPubMedCentral

39.

Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JTJ Jr (1996) Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 9(8):719–725PubMedCrossRef

40.

Magacho EJ, Ribeiro LC, Chaoubah A, Bastos MG (2011) Adherence to drug therapy in kidney disease. Braz J Med Biol Res 44(3):258–262. https://doi.org/10.1590/s0100-879x2011007500013CrossRefPubMed

41.

Moreira LB, Fernandes PFCBC, Mota RS, Monte FS, Galvao RIM, Sousa DF, Martins AMC (2008) Medication noncompliance in chronic kidney disease. J Nephrol 21(3):354–362PubMed

42.

Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM (2010) Low medication adherence and hypertension control among adults with CKD: Data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 56(3):447–457PubMedCrossRefPubMedCentral

43.

Njeri LW, Ogallo WO, Nyamu DG, Opanga SA, Birichi AR (2018) Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital. Int J Clin Pharm 40(5):1217–1224. https://doi.org/10.1007/s11096-018-0651-7CrossRefPubMed

44.

Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV (2010) Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol 32(6):541–548PubMedCrossRef

45.

Tangkiatkumjai M, Walker DM, Praditpornsilpa K, Boardman H (2017) Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study. Clin Exp Nephrol 21(3):504–512PubMedCrossRef

46.

Tesfaye WH, McKercher C, Peterson GM, Castelino RL, Jose M, Zaidi STR, Wimmer BC (2020) Medication adherence, burden and health-related quality of life in adults with predialysis chronic kidney disease: a prospective cohort study. Int J Environ Res Public Health 17(1):371CrossRefPubMedCentral

47.

Truong VT, Moisan J, Kröger E, Langlois S, Gregoire J-P (2016) Persistence and compliance with newly initiated antihypertensive drug treatment in patients with chronic kidney disease. Patient Prefer Adherence 10:1121PubMedPubMedCentral

48.

Wang SL, Chiu YW, Kung LF, Chen TH, Hsiao SM, Hsiao PN, Hwang SJ, Hsieh HM (2019) Patient assessment of chronic kidney disease self-care using the chronic kidney disease self-care scale in Taiwan. Nephrology 24(6):615–621PubMedCrossRef

49.

Wong KK, Velasquez A, Powe NR, Tuot DS (2018) Association between health literacy and self-care behaviors among patients with chronic kidney disease. BMC Nephrol 19(1):196. https://doi.org/10.1186/s12882-018-0988-0CrossRefPubMedPubMedCentral

50.

Molnar MZ, Gosmanova EO, Sumida K, Potukuchi PK, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP (2016) Predialysis cardiovascular disease medication adherence and mortality after transition to dialysis. Am J Kidney Dis 68(4):609–618PubMedCrossRefPubMedCentral

51.

Bowling CB, Vandenberg AE, Phillips LS, McClellan WM, Johnson TM, Echt KVJ (2017) Older patients’ perspectives on managing complexity in CKD self-management. Clin J Am Soc Nephrol 12(4):635–643PubMedCrossRefPubMedCentral

52.

McKillop G, Joy J (2013) Patients’ experience and perceptions of polypharmacy in chronic kidney disease and its impact on adherent behaviour. J Ren Care 39(4):200–207PubMedCrossRef

53.

Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB (2010) Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis 56(3):439–446PubMedCrossRefPubMedCentral

54.

Walker R, James H, Burns A (2012) Adhering to behaviour change in older pre-dialysis populations—what do patients think? A qualitative study. J Ren Care 38(1):34–42PubMedCrossRef

55.

Williams AF, Manias E, Walker R (2008) Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers’ and health professionals’ perspectives. Int J Nurs Stud 45(12):1742–1756PubMedCrossRef

56.

Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D (2002) The revised illness perception questionnaire (IPQ-R). Psychol Health 17(1):1–16CrossRef

57.

WHO (2003) Adherence to long-term therapies: evidence for action. World Health Organization, London

58.

Mechta Nielsen T, Frøjk Juhl M, Feldt-Rasmussen B, Thomsen T (2018) Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research. Clin Kidney J 11(4):513–527PubMedCrossRef

59.

Bartlett Ellis RJ, Welch JL (2017) Medication-taking behaviours in chronic kidney disease with multiple chronic conditions: a meta-ethnographic synthesis of qualitative studies. J Clin Nurs 26(5–6):586–598PubMedCrossRef

60.

Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA (2017) Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine 96(4):e5641–e5641. https://doi.org/10.1097/MD.0000000000005641CrossRefPubMedPubMedCentral

61.

Huang W-C, Chen C-Y, Lin S-J, Chang C-S (2016) Medication adherence to oral anticancer drugs: systematic review. Expert Rev Anticancer Ther 16(4):423–432. https://doi.org/10.1586/14737140.2016.1159515CrossRefPubMed

62.

Cramer JA (2004) A systematic review of adherence with medications for diabetes. Diabetes Care 27(5):1218–1224PubMedCrossRef

63.

Wang J, Chen Y, Xu W, Lu N, Cao J, Yu S (2019) Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: a meta-analysis. PLoS ONE 14(4):e0215362. https://doi.org/10.1371/journal.pone.0215362CrossRefPubMedPubMedCentral

64.

Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, Wiebe N, Ruospo M, Wheeler DC, Strippoli GF (2015) Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet 385(9982):2047–2056. https://doi.org/10.1016/s0140-6736(14)62459-4CrossRefPubMed

65.

Thomopoulos C, Parati G, Zanchetti A (2017) Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10—should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. J Hypertens 35(5):922–944. https://doi.org/10.1097/hjh.0000000000001276CrossRefPubMed

66.

Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM (2020) Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol 52:903–916. https://doi.org/10.1007/s11255-020-02452-8CrossRefPubMed

67.

Jackson C, Eliasson L, Barber N, Weinman JJ (2014) Applying COM-B to medication adherence: a suggested framework for research and interventions. Eur Health Psychol 16(1):7–17

Titel: Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel
verfasst von: Wubshet H. Tesfaye
Daniel Erku
Alemayehu Mekonnen
Yonas Getaye Tefera
Ronald Castelino
Kamal Sud
Jackson Thomas
Kehinde Obamiro
Publikationsdatum: 01.08.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Nephrology / Ausgabe 4/2021
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-020-00895-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objective

Method

Results

Conclusion

PROSPERO registration

Graphic abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Minimal change disease following vaccination for SARS-CoV-2

Hypertension and glomerular diseases: the importance of a holistic approach

Correction to: Is metformin associated with acute kidney injury? A case–control study of patients with type 2 diabetes admitted with acute infection

New predictive equations to estimate resting energy expenditure of non-dialysis dependent chronic kidney disease patients

The great help of a virus in the fight against bacteria!